Prescription drug · ANDA
Glipizide NDC 16714-896
Glipizide 10 mg/1 · Tablet, Extended release · Oral · Northstar Rx LLC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16714-896-01 | 1671408960116714089601 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-896-01)Marketed from Dec 1, 2018 | |
| 16714-896-02 | 1671408960216714089602 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-896-02)Marketed from Dec 1, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glipizide
- Generic name (nonproprietary)
- glipizide
- Active ingredients
- Glipizide — 10 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Northstar Rx LLC.NDC labeler code 16714
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203499
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonylurea Compounds (Chemical structure)
- Identifiers
- Product ID 16714-896_26f0c341-a482-4dc1-aaef-f0a92a84937cSPL ID 26f0c341-a482-4dc1-aaef-f0a92a84937cSPL set ID 915636a4-092e-4e2e-9bc0-0d387d996977RxCUI 310489, 314006, 315107UNII X7WDT95N5CUPC 0316714896014
- Pharmacologic class
- Sulfonylurea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N416714089601followed by a unit qualifier and the quantityPackage 16714-0896-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Glipizide extended-release tablets is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
Excerpt only. Read the full label for complete information.
About NDC 16714-896
- What is NDC 16714-896?
- 16714-896 is the product NDC for Glipizide, Glipizide 10 mg/1 tablet, extended release, listed with the FDA by Northstar Rx LLC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Glipizide.
- What is the active ingredient?
- Glipizide.
- Who is the labeler?
- Northstar Rx LLC., NDC labeler code 16714. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Glipizide?
- 135 other product NDCs are listed under this name. See all Glipizide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Glipizide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Glipizide | Glipizide 5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-117 | 11788-0117-0111788-0117-0511788-0117-10 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-118 | 11788-0118-00 |
| Glipizide | Glipizide 2.5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-120 | 11788-0120-0111788-0120-0511788-0120-10 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-579 | 72789-0579-3072789-0579-6072789-0579-86+3 more |
| Glipizide | Glipizide 10 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-580 | 72789-0580-3072789-0580-6072789-0580-86+3 more |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4178 | 68788-4178-0168788-4178-0368788-4178-06+2 more |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Coupler LLC | 67046-0367 | 67046-0367-03 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Coupler LLC | 67046-0236 | 67046-0236-03 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4061 | 68788-4061-0168788-4061-0368788-4061-06+2 more |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4017 | 68788-4017-0168788-4017-0368788-4017-06+2 more |
Other NDCs under ANDA 203499
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glipizide | Glipizide 2.5 mg/1 | Tablet, Extended releaseOral | Northstar Rx LLC. | 16714-894 |
| Glipizide | Glipizide 5 mg/1 | Tablet, Extended releaseOral | Northstar Rx LLC. | 16714-895 |
| Glipizide | Glipizide 10 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6848 |
| Glipizide | Glipizide 10 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-6849 |
| Glipizide | Glipizide 2.5 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3645 |
| Glipizide | Glipizide 10 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3896 |